Riskpilot← Back to searchSign inGet full accessBAUDER Nutrition AB
ABActiveOrg 5593648248Herrgårdsgatan 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20220 employees
Revenue 2024
SEK 234K
+1200% vs 2023
EBITDA margin
-483.8%
-3330% vs 2023
Equity ratio
2.1%
Financial strength
Net profit 2024
SEK -260K
-688% vs 2023
| Revenue | SEK 234K | +1200% |
| EBITDA | SEK -1,1M | -3330% |
| Net profit | SEK -260K | -688% |
| Total assets | SEK 1,1M | +4735% |
| Equity | SEK 23K | +0% |
| Employees | 0 | — |
Legal name
BAUDER Nutrition AB
Org number
5593648248
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 februari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva partihandel med läkemedel och därmed förenlig verksamhet, samt partihandel, dosförpackning och återförsäljning av näringstillskott.
Address
Herrgårdsgatan 16
Email
sai@bauder.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | −0 | 18 | 234 |
| Staff expenses | — | −0 | — | — |
| EBITDA | −9 | −9 | −33 | −1 132 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −9 | −0 | −33 | −1 132 |
| Net financials | — | 0 | — | −32 |
| Profit before tax | −9 | −9 | −33 | −260 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −9 | −9 | −33 | −260 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 22 | 22 | 23 | 1 112 |
| Equity | 16 | 16 | 23 | 23 |
| Long-term debt | 0 | 0 | 0 | 978 |
| Short-term debt | 6 | 6 | 1 | 112 |
| Total debt | 6 | 6 | 1 | 1 090 |
EBITDA margin
-483.8%
This company
15.8%
Market median
-3162% vs market
20222024
Equity ratio
2.1%
This company
38.2%
Market median
-95% vs market
20222024
Return on equity
-1130.4%
This company
18.4%
Market median
-6243% vs market
20222024
Net profit margin
-111.1%
This company
8.1%
Market median
-1472% vs market
20222024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20222024
Debt / equity
47.35×
This company
0.62×
Market median
-7537% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-09 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SV Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
SZ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BAUDER Nutrition AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sai Victor Bauder Fonturvel | Chief Executive Officer | 0 companies |
| Sindram Zarin Carolus Das Lövig | Deputy Chief Executive Officer | 0 companies |
| Ingegerd Margareta Bauder Fonturvel | Deputy Board Member | 0 companies |